IRCT20211008052698N1已完成2 期
Effect of low dose pamidronate in the treatment of thalassemia-induced osteoporosis
Oroumia University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Z-score < -2.5 in Bone Mineral Densitometry
- •Ferritin level>1000 mg/dl
- •More than 10 blood infusions or More than 100 cc/kg of blood infusion per year
- •Normal creatinine level
- •Normal blood counts
排除标准
- •The positive history of bone-related disorders
- •Leukemia or Neoplastic disorders
- •Gastrointestinal disorders
- •Chronic inflammatory diseases
研究者
相似试验
已完成
不适用
Study Into the Effect of Pamidronate for the Prevention of Heterotopic Ossification in High-Risk Patients: A Randomized Controlled TrialEstablished heterotopic ossificationMusculoskeletal DiseasesHeterotopic ossificationISRCTN01332857niversity Hospital of Basel (Switzerland)40
已完成
不适用
Efficacy and safety of minodronate in the treatment of glucocorticoid-induced osteoporosisJPRN-UMIN000011896Department of Medicine, School of Medicine, Nihon University30
已完成
不适用
Pamidronate and disease activity in rheumatoid arthritisRheumatoid arthritis.Seropositive rheumatoid arthritisIRCT138801051778N1Vice chancellery of research37
已完成
2 期
Oral low dose Amiodarone and prevention of atrial fibrillatioCoronary Artery Diseases.Atherosclerotic heart diseaseIRCT201207303799N4Tehran University of Medical Sciences Vice chancellor for research170
已完成
不适用
Therapeutic effect on disodium pamidronate administration to diffuse sclerosing mandible osteomyelitisdiffuse sclerosing osteomyelitisJPRN-UMIN000033725Department of Oral and Maxillofacial Surgery, Osaka Medical and Pharmaceutical University5